Clinical Trials Logo

Retroperitoneal Sarcoma clinical trials

View clinical trials related to Retroperitoneal Sarcoma.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05044624 Completed - Clinical trials for Retroperitoneal Sarcoma

Retroperıtoneal Soft-Tıssue Sarcomas

Start date: March 1, 2016
Phase: N/A
Study type: Interventional

: Soft Tissue Sarcomas are rare mesenchymal tumors with many subtypes. Clean margin-wide resection is recommended for treatment. The guidelines recommend that sarcoma treatments be carried out in sarcoma centers. In this study, the location, histopathological features, clinical and demographic features, recurrence, and prognosis of retroperitoneal sarcomas were investigated.

NCT ID: NCT04225494 Completed - Clinical trials for Intraoperative Hypotension

Perioperative Residual Adrenal Function After Extended Resection for Retroperitoneal Soft Tissue Sarcomas

RAF
Start date: June 1, 2019
Phase:
Study type: Observational [Patient Registry]

Early recognition of adrenal function deficit in patients undergoing multivisceral surgery including adrenalectomy for primitive retroperitoneal sarcomas

NCT ID: NCT03877588 Completed - Malnutrition Clinical Trials

Nutritional Status in Retroperitoneal Sarcoma.

NOVA
Start date: December 6, 2016
Phase: N/A
Study type: Interventional

Prospective feasibility study of perioperative nutrition in patients affected by primary retroperitoneal sarcoma

NCT ID: NCT02384473 Completed - Bone Sarcoma Clinical Trials

Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue Sarcoma

Start date: December 24, 2014
Phase: Early Phase 1
Study type: Interventional

This pilot clinical trial studies real-time contrast-enhanced ultrasonography and shear wave elastography in predicting treatment response in patients with soft tissue sarcomas. Ultrasonography and elastography are diagnostic imaging tests that use sound waves to make pictures of the body without using radiation (x-rays). Real-time contrast-enhanced ultrasonography and shear wave elastography may help measure a patient's response to treatment given before surgery in patients with soft tissue sarcoma.